For adults navigating chronic stress — an increasingly universal condition — the prospect of a dietary compound that could actively repair stress-damaged brain circuitry carries real weight. Most interventions target stress symptoms; far fewer address the underlying hippocampal deterioration that chronic stress quietly accelerates. This mouse study positions naringin, a bioflavonoid abundant in grapefruit and other citrus, as a candidate that may do both.
Using a well-validated chronic unpredictable mild stress (CUMS) protocol over 21 days, researchers divided adult male mice into six groups (n=9 per group) and administered naringin at doses of 2.5, 5, and 10 mg/kg, comparing outcomes against fluoxetine (10 mg/kg) as an active control. The 10 mg/kg naringin dose produced the most robust effects: measurably improved spatial and recognition memory on Y-Maze and novel object recognition tasks, reduced nitrite levels and acetylcholinesterase activity, restored depleted antioxidant enzymes (glutathione, superoxide dismutase, catalase), and blunted CUMS-elevated proinflammatory cytokines TNF-α and IL-1β. Immunohistochemical analysis further indicated recovery of neuroplasticity-related hippocampal proteins, suggesting structural as well as biochemical restoration.
Placing this in context, naringin's antioxidant and anti-inflammatory profile has been studied across metabolic and cardiovascular domains, but its application to stress-induced neurodegeneration is comparatively underexplored. The dual action on oxidative burden and neuroinflammation is theoretically compelling — both pathways converge on hippocampal volume loss seen in chronic stress and depression. However, several limitations temper enthusiasm: this is an all-male mouse study with a small per-group sample size, and animal CUMS models, while informative, are imperfect proxies for human stress-related cognitive decline. Bioavailability of naringin in humans after oral ingestion is substantially modified by gut microbiota, making dose translation non-trivial. Overall, this is a mechanistically detailed but incremental preclinical finding that justifies further investigation, not yet clinical application.
